Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 03, 2015 10:29 PM ET

Pharmaceuticals

Company Overview of SynGlyco, Inc.

Executive Profile

Peter H. Seeberger Ph.D.

Co-Founder, Director and Member of Scientific Advisory Board, SynGlyco, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Peter H. Seeberger PhD serves as Co-Founder of Ancora Pharmaceuticals and serves as Scientific Advisor to several companies including 3M. Dr. Seeberger co-founded i2Chem Inc., in 2010. He has been a Professor at the Free University of Berlin since 2009. Until 2006, he served as President of the Swiss Academy of Natural Sciences. Dr. Seeberger served as Special Consultant of Chemistry Group of Glycogenesys Inc. since January 5, 2005. He served as Scientific Advisor ...

Corporate Headquarters

200 Boston Avenue
Medford, Massachusetts 02155

United States

Phone: 781-395-7700
Fax: 781-395-7900

Board Members Memberships

Co-Founder, Director and Member of Scientific Advisory Board
Director

Education

PhD 1995
University of Colorado–Boulder
BS 1989
Friedrich-Alexander-Universität Erlangen-Nürnberg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SynGlyco, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.